medline.ch Dermatologie Tumoren Anderes

	Objective response rate predicts survival in recurrent or metastatic head and neck squamous cell carcinoma treated with immune checkpoint blockade but not with targeted therapy: A retrospective multicenter study. Cancer Inoue T, Kono M, Kumai T, Obata K, Kano S, Ohkoshi A, Kakiuchi A, Taguchi J, Tagawa A, Matsushita D, Miyaguchi J, Endo T, Ishii R, Ito K, Ishida E, Suzuki T, Araki N, Kawase T, Takano K, Takahara M. PMID: 42011717 [PubMed - indexed for MEDLINE]
	Pre-operative Serum Hepatocyte Growth Factor and Inflammatory Prognostic Score as Prognostic Markers in Oral Squamous Cell Carcinoma. J Vis Exp Xu P, Hua L. PMID: 42008413 [PubMed - indexed for MEDLINE]
	CircRNAs in Cutaneous Squamous Cell Carcinoma: Emerging Biomarkers and Potential Therapeutic Targets. Cell Biochem Funct Zou J, Qian W, Guo J. PMID: 42007522 [PubMed - indexed for MEDLINE]
	Corrigendum to: Effects of SVEP1 on Lung Squamous Cell Carcinoma and its Association with Tumor Mutation Burden, Prognosis, and Immune Regulation. Comb Chem High Throughput Screen Luo Y, Zhang M, Wang Z, Li Z, Chen X, Cao J, Que J, Chen L, Deng X. PMID: 42003235 [PubMed - indexed for MEDLINE]
	Assessment of Programmed Cell Death Ligand-1 Expression in Oral Potentially Malignant Disorders and Tumor-Free Surgical Margins of Oral Squamous Cell Carcinoma: Protocol for a Retrospective Cross-Sectional Study. JMIR Res Protoc Sonone A, Hande A, Patil S, Pakhale A, Sharma P. PMID: 41990236 [PubMed - indexed for MEDLINE]
	Esophageal cancer: from pathogenesis to precision therapies. Signal Transduct Target Ther Zhang S, Shen Y, Zhu L, Lai Y, Zhu L, Xiao X, Li J, Tan W, Lin D, Wu C. PMID: 41986343 [PubMed - indexed for MEDLINE]
	Lifestyle and Environmental Risk Factors for Esophageal Squamous Cell Carcinoma: Evidence From the Johannesburg Cancer Study. JCO Glob Oncol Chen WC, Bradshaw D, Ramaliba T, Babb de Villiers C, Newton R, Waterboer T, Mathew CG, Muchengeti M, Sitas F. PMID: 41985117 [PubMed - indexed for MEDLINE]
	Radiation-induced remodeling of the T cell landscape in head and neck cancer. Cancer Immunol Immunother Memon AA, Said I, Norenberg E, Frei A, Foeckler J, Sun F, Dwinell MB, Lochhead RB, Bruening J, Akakpo K, Massey B, Wong SJ, Hematti P, Kearl TJ, Awan MJ, Himburg HA, Zenga J. PMID: 41984232 [PubMed - indexed for MEDLINE]
	Efficacy of first-line immune checkpoint inhibitors for recurrent/metastatic head and neck cancer: a systematic review and meta-analysis. Immunotherapy Zhou J, Tang W, Xue L. PMID: 41979190 [PubMed - indexed for MEDLINE]
	Molecular Mechanisms in Oral Squamous Cell Carcinoma: Integrative Roles of Cancer-Associated Fibroblasts, Immune Microenvironment, and Precision Therapeutic Opportunities. Int J Mol Sci Tsai CC, Hsu PC, Kuo CY. PMID: 41977145 [PubMed - indexed for MEDLINE]
	Circulating Tumour Cells as Potential Biomarkers for Oral Squamous Cell Carcinoma. Molecules Mabongo M, Chipiti T, Hull R, Sibiya L, Phakathi B, Dlamini Z. PMID: 41976187 [PubMed - indexed for MEDLINE]
	Fungating Mass of the Glans Penis: A Case Report and Discussion on Penile Squamous Cell Carcinoma. J Investig Med High Impact Case Rep Collins DM, Simpkins AM, Diks J, Robertson D. PMID: 41972286 [PubMed - indexed for MEDLINE]
	The construction of CD8+ T cell-associated molecular subtypes in esophageal squamous cell carcinoma reveals tumor heterogeneity, tumor microenvironment, and immunotherapy. Front Immunol Cao S, Jiang H, Li Y, Yang K, Tian L, Li L. PMID: 41972154 [PubMed - indexed for MEDLINE]
	Survival benefit and dynamics of CD8(+) T cells and tumor-associated macrophages in neoadjuvant immunochemotherapy vs. chemotherapy for locally advanced esophageal squamous cell carcinoma: an IPTW-adjusted real-world study. Front Immunol Gan Y, Li Y, Fang L, Chen Y, Yang D. PMID: 41972149 [PubMed - indexed for MEDLINE]
	Prediction of clinically significant complication following neoadjuvant chemoimmunotherapy in resectable esophageal cancer: a dynamic systemic inflammatory biomarker-based model. Front Immunol Chen M, Yang Z, Huang Y, Li H, Zeng T, Zhang S, Huang G, Chen C, Zheng B. PMID: 41958656 [PubMed - indexed for MEDLINE]
	Phase 1b study of ABBV-368, tilsotolimod, budigalimab, and nab-paclitaxel in patients with recurrent/metastatic head and neck squamous cell carcinoma. J Immunother Cancer Daste A, Le X, Makkouk A, Patel M, Le Tourneau C, Perets R, Popovtzer A, Ochsenreither S, Haderlein M, Oliva M, Sukari A, Hong J, Blaney M, Ramathal C, McDevitt M, Rosenberg AJ. PMID: 41956545 [PubMed - indexed for MEDLINE]
	Analysis of histological parameters of aggressiveness in resected lung squamous cell carcinoma. Pathologica Impalà GA, Pittaro A, Guerrera F, Sobrero S, Bogina G, Orlando G, Zambelli V, Napoli F, Leo F, Ruffini E, Volante M, Papotti M, Righi L. PMID: 41954360 [PubMed - indexed for MEDLINE]
	Directions in Nonmelanocytic Tumors: Squamous Cell Carcinoma and Merkel Cell Carcinoma. Dermatol Clin Elsensohn A. PMID: 41951324 [PubMed - indexed for MEDLINE]
	Squamous Precursor Lesions of the Vulva: A Practical Approach. Dermatol Clin Crimmins J, Schneider MM, Selim MA. PMID: 41951322 [PubMed - indexed for MEDLINE]
	Plasma progastrin levels in patients with oral squamous cellcarcinoma - a cross-sectional study. Tunis Med Kumar M, V A, Kumaravel S, Kannan R, Narayanan A. PMID: 41949947 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 60075

Seite 1 von 3004

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung